---
title: "Recursion Pharmaceuticals (RXRX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RXRX.US/norm.md"
symbol: "RXRX.US"
name: "Recursion Pharmaceuticals"
parent: "https://longbridge.com/en/quote/RXRX.US.md"
datetime: "2026-05-20T16:41:27.910Z"
locales:
  - [en](https://longbridge.com/en/quote/RXRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RXRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RXRX.US/norm.md)
---

# Recursion Pharmaceuticals (RXRX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2220 | -0.2053 | -0.3630 | -0.4119 | -0.5027 |
| ROE | -43.61% | -39.72% | -66.02% | -74.21% | -82.28% |
| Revenue | 6.47M | 35.54M | 5.17M | 19.22M | 14.74M |
| Net income | -117.50M | -108.12M | -162.25M | -171.90M | -202.49M |
| Operating income | -128.50M | -116.85M | -172.20M | -176.23M | -191.37M |
| Gross margin | -1451.08% | -210.13% | -2523.17% | -674.06% | -927.22% |
| Net margin | -1815.57% | -304.24% | -3135.32% | -894.23% | -1373.26% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.34B | 1.47B | 1.40B | 1.30B | 1.31B |
| Leverage | 1.31 | 1.30 | 1.34 | 1.42 | 1.40 |
| BVPS | 1.93 | 2.14 | 2.13 | 2.12 | 2.30 |
| Turnover | 0.0502 | 0.0511 | 0.0411 | 0.0622 | 0.0642 |
| Cash & STI | 654.47M | 743.29M | 659.84M | 525.11M | 500.45M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 157.32M | 169.48M | 181.24M | 193.60M | 204.78M |
| Net debt | -582.10M | -665.33M | -577.46M | -437.04M | -407.54M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -81.10M | -46.07M | -117.36M | -76.42M | -131.96M |
| Investing CF | -338000.00 | -1.24M | -2.55M | -5.81M | -7.27M |
| Financing CF | -3.47M | 132.01M | 251.34M | 97.66M | 40.53M |
| Free CF | -42.90M | -55.19M | -62.88M | -22.16M | -73.53M |
| OCF coverage | -3288.77% | -1350.72% | -4951.90% | -1460.03% | -3401.83% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -258000.00 | -1.24M | -243000.00 | -3.15M | -1.83M |